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A group of toxins produced by Staphylococcus aureus has long been known to be
responsible for a number of human diseases, including food poisoning and toxic
shock (1, 2). It is also known that these toxins are powerful stimulators of human
and mouse T cells (3-7). Recently, several groups have shown that some, and per-
haps all, of these toxins bind to class II MHC proteins in man and, somewhat less
well, in mouse (8-10). We and others have also shown that the ability ofhuman and
mouse T cells to respond to S. aureus toxins requires that the toxins first be bound
to class II molecules on presenting cells, and that the ability of T cells to respond
to the combination of toxin and MHC depends upon the structure of the TCR,
in particular upon the Vii segment of the receptor. T cells bearing human V,68 or
mouse V011, for example, respond very well to S. aureus enterotoxin E, whereas re-
sponses to the toxic shock-stimulating toxin are driven mainly by human T cells
bearing V/32 or mouseT cellsbearing V015 or -10 as part oftheir receptors (6, 7, 11, 12).
It is not known why these toxins are pathogenic. Since they bind to class II mole-
cules on macrophages and other class II' cells, their toxic effects could be medi-
ated by stimulation of such cells to produce mediators with toxic effects, such as
cachectin/TNF, IL-1, or leukotrienes (13-18). Alternatively, the toxins may cause disease
because they stimulate large numbers of T cells to divide and secrete certain lym-
phokines at high levels, such as IL-2 or TNF. Finally, the staphylococcal toxins may
lead to pathogenesis by a T cell/class II independent and unknown mechanism .
In this work, we have studied the pathogenic effects of one staphylococcal toxin,
enterotoxin B (SEB)', on mice. Administration of the toxin to mice causes weight
loss and immunosuppression in a dose-dependent fashion. The degree ofweight loss
induced is related to the MHC haplotype of the mice challenged. Nude mice, which
almost completely lack T cells, or mice constructed genetically such that they con-
tain few T cells able to respond to SEB, suffer little or no loss in weight when SEB
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is given to them. Mice containing normal numbers of T cells, but deficient in those
able to respond to SEB, are not immunosuppressed by the toxin. These results sug-
gest that some or all of the pathogenic effects of SEB in mice, and perhaps man,
are caused by the potent ability of the toxin to stimulate T cells.
Materials and Methods
Mice.
￿
B10.BRSgSn, CBA/J, and (C57B1/6 x BALB/c)F, nude and littermate animals
were purchased from The Jackson Laboratory (Bar Harbor, ME). B10.BROBR mice, car-
rying the TCR 0 chain locus derived from C57Ls, were derived as previously described (19).
These and other animals were bred in the animal care facility at the NationalJewish Center
for Immunology and Respiratory Medicine.
Response to Antigen.
￿
Animals were primed in the base of the tail, as previously described
(20), with 100 hg hen egg lysozyme (HEL) (Sigma Chemical Co., St. Louis, MO) in CFA.
7 d later, cells were harvested from the draining lymph nodes of these animals, and T cells
were purified by passage over nylonwool (21). T cells were titrated for response into cultures
containing 1,000-rad irradiated antigen-presenting syngeneic spleen cells and 1 mg/ml HEL
or purified protein derivative (PPD) (Parke Davis Corp.). 4 d later, responses in these cultures
were monitored using 3-(dimethylthiazol-2-yl)-2,5-diphenyl tetrajolium bromide (MTT) as
previously described (22).
Analysis of Vii Expression.
￿
T cells were prepared from samples ofperipheral blood as previ-
ously described. Aliquots of the cells were incubated with biotinylated anti-a/0, antiV03,
antiV06, antiV07, or antiV/38 antibodies (23-26). After washing, reactive cells were stained
with phycoerythrin coupled to avidin, and analyzed using an Epics C flow cytometer.
Measurements ofAnimal Weight.
￿
Mice were confined, three to a cage, for at least 1 wk before
beginning an experiment to allow social relationships to stabilize in the group. We found
that mouse weight varied considerably, even in unmanipulated animals, for a few days after
mice were transferred to new groups; thus, the preexperimental period of 1 wk was used
to avoid complications in our experiments due to this factor. Mouse weight varies somewhat
at different times of day, therefore, in any given experiment, mice were always weighed daily
at the same time, usually between 12:00 noon and 4:00 pro. Mice were weighed using a bal-
ance that allowed accurate determination to within 0.1 gm.
To determine the effects of toxins on weight, mice were weighed 24 h before, and at the
time of, toxin administration. They were then weighed at 24-h intervals thereafter. All mice
in a given cage were given the same dose oftoxin, to avoid contamination with toxin between
individuals, because of toxin acquisition by grooming, for example.
Weight changes are shown as percent weight gain or loss compared with the weight of
the animal before toxin administration.
Cyclosporin Treatment.
￿
Cyclosporin A (CSA) was a gift of Sandoz Pharmaceutical Corp.,
East Hanover, NJ. Animals were given 25 mg/kg cyclosporin in 30-40 ill olive oil in-
traperitoneally every day. Controls received olive oil alone. This dose of CSA has been shown
to affect T cell development and function in vivo in mice (27). In our hands, effects were
comparable with those published; this dose of CSA completely prevented the appearance of
mature thymocytes in vivo. Mice were treated with CSA for 1 wk before toxin administra-
tion, and throughout the duration of the experiment. Neither CSA nor olive oil treatment
had any effect on the weight of mice in the absence of SEB.
Results
Effects of Staphylococcal Enterotoxin B on Normal Mice.
￿
Groups of three 12-wk-old
B10.BR mice were given doses of SEB ranging from 0 to 100 hg, i.p. The animals
were weighed daily. As shown in Fig. 1, the animals suffered a rapid dose-dependent
weight loss that was most profound 1 or 2 d after toxin administration. Similar effects
were seen in many duplicate experiments, with some variations in the effects of aDays After SEB
3
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FIGURE 1.
￿
Dose dependence ofweight loss after SEB administration.
Groups ofthree B10.BRmicewere caged separately for 1 wk and given
the indicated dose of SEB intraperitoneally on day 0. Mice were
weighed at this time and daily at the same time thereafter. Shown
are the averaged percent weight losses by comparison with the weight
ofeach mouse on day 0. Bars indicate the SEs of percentage weight
loss within each group ofmice. On day 0, the mice each weighed be-
tween 20 and 25 g. (r) 100,ug SEB; (/) 33 pg SEB; (A) 10 jug SEB;
( ") 0 ug SEB.
particular dose of toxin. In one experiment, for example, all mice given 100 ug of
SEB actually continued to lose weight over 3 d and eventually died.
4 d after the mice described above were given toxin, they were killed, and the
effects ofthe toxin on the mice were evaluated. Macroscopically, there was no effect
on the gut, lungs, or liver, which all appeared normal in SEB-treatedmice. Animals
given high doses of toxin did contain less fat, however. For example, the fatty tissue
surrounding the inguinal lymph nodes was significantly diminished in these mice.
There was no significant change in the size ofthelymph nodes and spleens ofanimals
given toxin, nor was there a significant change in the numbers of T cells harvested
from lymph nodes. The sizes and cellularity of the mouse thymuses were affected,
however. As shown in Table I, the yield of thymocytes from SEB-treated animals
was substantially less than that of normal mice of the same age. Again, the effects
of SEB were dose dependent.
Analysis ofV(3expression on lymph node T cells from these animals showed that,
although their totalnumbers were unaffected by the toxins, therehad been aconsid-
erable effect of the toxins upon their composition. For example, the percentage of
V08-bearing cells rose from x+31% in normal B10.BR mice, to -51% in mice given
100 /Ag SEB. Conversely, the percentage of V(36-bearing cells dropped from -15%
to <10% (Table 1). These changes were predicted by the known V/3 specificity of
SEB, since we and others have previously shown that this toxin stimulates T cells
bearing V03, -7, and -8, but not those bearing V(36 (6, 7). These results are best
TABLE I
The Effects of SEB on Thymocytes and Lymph Node T Cells
Results shown are the mean and SE of data from three mice.
SEB dose
Thymocytes/
mouse x 107 VS3
percent lymph node
V06
T cells bearing:
V07 Vas
#9
0 9.1 t 1 .8 6.4 f 0.4 14.9 t 0.6 4.5 f 0.5 30.9 ± 0.7
10 6.6 t 2.0 4 .6 t 0.3 12 .1 t 1 .6 4.6 t 0.6 40.9 t 6.2
33 3.0 ± 0.4 5.0 ± 0.1 10.4 ± 0.6 4.8 t 0.3 43.9 t 1 .8
100 1.7 ± 0.6 5.2 ± 0.2 9.7 t 0.3 6.0 t 0.4 51 .3 t 2.2458
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interpreted as an increase in those T cells bearing receptors with which SEB could
interact, and a concomitant decrease in nonreactive T cells.
It has previously been reported that administration of SEB suppresses in vivo im-
mune responses in mice (28, 29) . To confirm this, under the conditions used in these
experiments, mice were given different amounts of SEB and then immunized with
HEL in CFA. HEL was chosen because responses to it in H-2k animals are not
dominated by T cells bearing V/3s, which interact with SEB. Instead, anti-HEL re-
sponses in such animals are often those of Voll-bearing cells (30).
7 d after immunization with HEL, draining lymph nodes were removed from the
mice, and the T cells in them harvested and titrated for response to HEL or PPD,
the major antigen in the mycobacteria in CFA. 3 or 4 d later, the proliferative re-
sponses in these cultures were measured.
As shown in Table II, substantially fewer T cellswere harvested from immunized
animals that had been previously given SEB. These cells also responded less well
to HEL or PPD than those from control animals that had not been pretreated with
SEB. Overall, the total T cell response/mouse recovered from animals given high
doses of SEB was <20% of that from control animals. Mice given lower doses of
SEB had less reduced responses to antigen.
Although SEB administration had several demonstrable effects in these experi-
ments, we chose to measure weight loss as an indication of toxicity in our further
studies because the phenomenon was reproducible, easily applied as a time course,
and sensitive to toxin dose.
The Mouse MHC Type Affects its Response to SEB.
￿
In an attempt to find out whether
there was any relationship between the MHC molecules available for SEB presenta-
tion in animals, and the toxic effects of SEB, we studied the consequences of ex-
posure to SEB on B10 .BR (IAk+, IEk+) and B10.A(4R) (IA', IE -) mice. First, the
toxin was titrated into cultures of purified B10.BR or B10.A(4R) T cells and syn-
geneic APC. The toxin was about an order of magnitude more effective, dose for
dose, in stimulating B10.BR cells than cells from B10.A(4R)s (Fig. 2 A). This was
probably because the toxin binds more efficiently to IEk than to IA', as has been
suggested by others (6).
The effects of SEB on these two strains of mice in vivo were then measured. Groups
TABLE II
Immunosuppressioe Effects of SEB
Mice were given the indicated dose of SEB, or an equivalent volume of balanced salt solu-
tion. 3 d later, they were immunized with HEL in CFA. 7 d after immunization, draining
lymph node cells were harvested, and T cells were purified and titrated for response to HEL
or PPD. Proliferative responses/input T cell or responses/mouse were calculated and nor-
malized to those of the BSS-treated control animals.
SEB dose
Fig
0
Lymph node
T cells/mouse
x 101,
14.0
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HEL/T cell
100
to :"
HEL/mouse
100
Response
PPD/T cell
100
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PPD/mouse
100
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FIGURE 2.
￿
Theresponse toSEBin vitroandin vivo
is similarly MHC dependent. (A) (Invitro) T cells
were prepared from B10.BR(0)or B10.A(4R) (")
animals and titrated into cultures containing
saturating irradiated APC and 1 Kg/ml SEB. Prolifer-
ation was assayed 3 d later using MTT (22). Data
shown aretheaverages oftriplicate cultures. (B)(In
vivo)Groups ofthreeBl0.BR(O)or B10.A(4R) (")
mice were housed, treated with SEB, and weighed
as described in the legend to Fig. 1.
of three mice of either strain were given balanced salts solution or 50 Jug SEB in-
traperitoneally, and weighed daily. As shown in Fig. 2 B, weight loss of B10.A(4R)
animals was small, and the mice recovered rapidly. B10.BR animals, on the other
hand, suffered a more profound and more prolonged weight loss.
These results suggested that the toxic effects of SEB were related to the ability
of the toxin to bind MHC, either because binding to class II caused cells bearing
such MHC proteins to secrete toxic products, such as IL-1, or because binding to
class II triggered some other toxic event in the animals, for example, massive Tcell
stimulation.
T011-deficient Animals Are Less Susceptible to the Toxic Elects ofSEB.
￿
Mice were made
T cell deficient in two ways. In the first, animals were treated daily with a dose of
CSA in olive oil known to suppress lymphokine secretion. These animals and con-
trols were then given SEB. Cyclosporin-treated animals suffered no weight loss as
a consequence of the CSA. Control and CSA-treated animals did not lose weight
after administration of balanced salts solution. Control mice given SEB lost weight
as expected. Weight loss ofSEB-treatedmice was smallerandless prolonged (Fig. 3).
These results suggested that T cell release of lymphokine in response to SEB was
partially or completely responsible for weight loss in mice induced by SEB. Since
we had no independent measurement of the effectiveness of the CSA treatment on
lymphokine release in vivo, we could not be sure that the residual effects of SEB
in CSA-treated animals were due to incomplete suppression of the T cell responses
in these animals by the dose of CSA we used.
In a second approach to this problem, nude (C57B1/6 x BALB/c)Fj mice, and
theirlittermate controls, were treatedwith SEB. As shown in Fig. 4, Tcell-deficient
FIGURE 3.
￿
Cyclosporin partially prevents weight loss dueto SEB
administration.Groups ofthree B10.BR mice were housed, treated
with SEB, and weighedas described in the legend to Fig. 1. Two
groups received 25 mg/kgSEB in oliveoildaily (squares), and two
control groups received oliveoilalone(circles). On day0, twogroups
received 50 jig SEB/mouse intraperitoneally (closed symbols) and
two received an equal volume of balanced salts solution (open
symbols). Themice were weighed at this time anddaily thereafter
and the results calculated as described in thelegend to Fig. 1. SEs
on the values ranged from 0.6 to 4.6%.
In Vitro in Vivo
BIO.A(4R)
B10BR 1 /~~
B10.BR V
BI0.A(4R)
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￿
TOXICITY MEDIATED BY T CELLS
z
I
0
v
O 3
J
a, 4
3 e
6
7
2
￿
3
￿
I
Days after SEB
FIGURE 4.
￿
SEB does not induce weight loss in nude
mice. (C57B1/6 x BALB/c)F, nude and wild-type lit-
termates werepurchasedfrom TheJacksonLaboratory.
On day 0, mice were given 125 Wg SEB or balanced
salts solution intraperitoneally. Animals were housed,
weighed, and the results were calculated as described
in the legend to Fig. 1. (") SEB-treated mice; (O)
balanced salt solution-treated mice.
nude animals suffered no significant weight loss after SEB injection, whereas their
T cell-positive littermates did. The effects of SEB in these Fts were not as powerful
as in B10.BR mice, probably because of the difference in MHC haplotype.
SEB Is Less Toxic in Mice Deficient in SEB-reactive T Cells.
￿
The experiments de-
scribed above strongly suggested that weight loss caused by SEB was due to T cell
reactions. To prove this definitively, we decided to breed a collection of mice that
would containvaryingnumbers of SEB-reactive T cells. This enterotoxinstimulates
mouse T cells bearing V03, -7, -8.1, -8.2, and -8.3. V08-bearing cells are absent
in mice carrying the C57BRderived V(3 locus, which lacks the genes for these V#s
(31). V03-bearing Tcells are suppressed in mice expressing the mouse superantigens,
Mls-2a and/or Mls-3a, and a permissive MHC haplotype (24, 32, 33). V07-bearing
T cells are deleted in mice expressing a self superantigen, which is, or maps closely
to, Mls-la, and a permissive MHC haplotype (Drs. D. Woodland and E. Palmer,
personal communication). IEk is functional for presentation of these superantigens.
Mice containing theC57BRderived V0 locusdo contain a functional gene forV017a.
T cells bearing V017a do respond well to SEB (J. Callahan, unpublished results).
V017a+ cells are almost completely absent from the mice used in these experiments,
however, as a result of clonal deletion caused by expression of IEk (34) .
(B10.BROBR x CBA/J)Fl mice were therefore created, and male Fls backcrossed
to B10.BROBR. All these animals express IEk. B10.BROBR animals are homozy-
gous for the C57BR-derived, Va8- , V/3 locus. CBA/J animals express Mls-la and
Mls-2a, and/or Mls-3a; these superantigens are dominant in Fts, and will cause the
deletion of most T cells bearing V03, -6, -7, and -8.1 (24, 32, 33, 35, 36). Among
the backcrossed animals, we therefore expected that about half the animals would
be homozygous for theV08deletion, and about halfwouldbe heterozygous forMls-
la or its associated superantigen expression, and therefore delete V(07 (and V06)-
bearing cells. At the time we started this breeding, it was not known which of the
V03-deleting superantigens were expressed in CBA/J mice. We therefore expected
that either half or three-quarters of the backcrossed animals would express one, the
other, or both of the superantigens Mls-2a and Mls-3a. Since none of these Vo-
deleting loci are genetically linked, we expected that aboutone-eighth of the animals
would contain few SEB-reactive T cells, and about one-eighth would contain a rea-
sonable number of these cells.
Animals were typed for V(3 expression using samples of their peripheral blood.
Normal Nude
Control
SEB
~ 1 Control
SEBThe frequencies with which T cells bearing different VQs were deleted were very
much as expected. Of rv 100 mice typed, 46% were homozygous for the B10.BROBR
VO-deleted chromosome. 54% of the mice eliminated V/37-bearing T cells, prob-
ably due to Mls-1a expression. 380 1o of the animals eliminated V03+ cells. This last
result indicated that CBA/J animals carry either Mls-2a or Mls-3a, but not both.
Animals expressing low and high frequencies of SEB-reactive T cells were given
SEB intraperitoneally, and weighed daily thereafter (Fig. 5). Mice containing few
reactive cells were barely affected by the toxin, whereas their littermates containing
more T cells that would be stimulated by SEB rapidly lost weight. Preliminary ex-
periments indicated that none of these animals suffered changes in thymus size due
to toxin administration, perhaps because the numbers ofreactive T cells in the mice
were below the threshold required for this effect.
Discussion
It is apparent that SEB has a number of pathological effects in susceptible mice,
causing rapid weight loss, thymus depletion, and immunosuppression. The data in
this paper demonstrate that the weight loss at least is dependent upon T cell activa-
tion caused by the toxin, since animals containing few SEB-reactive T cells, either
because of genetic defects or because of cyclosporin-mediated immunosuppression,
lose little or no weight after challenge with SEB. This idea is supported by the fact
that SEB administration has no effect on the weight of neonatal mice, whichcontain
very few mature T cells (7, and personal observations).
The consequences of SEB-mediated T cell activation on thymus size and T cell
responsiveness could not, of course, be measured in thymus-deficient or cyclosporin-
treated animals. The toxin did not, however, affect thymus size in B10.BROBR x
CBA/J backcrossed animals, mice that contained -13% fewer SEB-reactive T cells
than their B10.BR relatives in which SEB did cause thymus depletion. This result
suggests that massive Tcell activation mediated by SEB maybe required for significant
thymus depletion.
It appears, therefore, that much or all of the measurable pathological effects of
SEB in mice are indirect consequences of T cell activation caused by the toxin. At
present, it is notclearhowT cell activation has such effects. It is likely that the SEB-
activated T cells secrete large amounts of a number of different lymphokines, in-
cluding IL-2 and cachectin, both of which have been shown to have toxic effects
similar to those described for SEB in mouse and man (16, 17, 37, 38).
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FIGURE 5.
￿
Weight loss induced by SEB is proportional to the
numbers of SEB-reactive T cells in the mouse. BIO.BROBR x
(BIO.BRRBR x CBA/J)Fl animals were bred. Theirpercentages
of peripheral bloodTcells bearing V03, -6, -7,and -8 were evalu-
ated (19). Mice were caged in groups ofthreeaccordingto theper-
cent of SEB-reactive T cells they expressed. Animals were given
50 pg of SEBon day0, andtheeffects ofthe toxin on theirweight
were monitored as described in the legend to Fig. 1. (/, A)
B10.BRSBR x (B10.BROBR x CBA/J)Fl mice containing 6.3 t
0.4 and 27.6 ± 1.6% SEB-reactive Tcells, respectively. (") B10.BR
mice containing 35% SEB-reactive T cells.462
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The staphylococcal toxins are potent stimulants for human T cells, as well as for
thoseof mice (3-7). In addition, the toxins have, ofcourse, a number ofpathological
effects in man, including diarrhea, vomiting, and shock (1, 2). In light of the conclu-
sions of this paper, it is worth asking whether some or all of these effects may be
due to T cell activation and consequent lymphokine secretion. Since massive T cell
activation in man, after anti-CD3 administration, or infusion of large quantities
of a T cell-derived lymphokine and stimulator, IL-2, has been reported to cause
shock, in a fashion similar to some of the staphylococcal toxins, we would like to
suggest that this is so.
In the past, the preferred animal models for studies of staphylococcal toxins have
been rabbits, monkeys, or primates. Relatively little work, except on the staphylococcal
exfoliating toxins, has been done in mice (39). Probably, this is due to the fact that
high doses of the toxins, by comparison with those that cause pathology in man,
are needed to cause disease in mice. In fact, some strains ofmice are almost unaffected
by SEB (personal observations). It is an educated guess that the difference in dose-
response curves to SEB between man and mouse is primarily due to the fact that
SEB binds to human class II proteins with much higher affinity than it binds to
mouse classII (Drs. J. Fraser and A. Herman, personal communication). Sincebinding
to class II is a prerequisite for T cell activation, this could easily account for the
difference in susceptibility ofthe two species. In this context, it is worth mentioning
that aureus is not the species ofStaphylococcus found on mice (40). Staphylococcus xylosus,
the species found on mouse, may secrete toxins with higher affinity for mouse MHC,
and consequently, a lower threshold for pathological effects.
Summary
Staphylococcal enterotoxin B (SEB) has been shown in the past to be a potent
T cell stimulant in mouse or man. The toxin acts as a superantigen that is, it binds
to class II MHC proteins and, as such a complex, stimulates T cells bearing partic-
ular Va as part of their receptors. The toxin also has several pathological effects,
causing, in mice, rapid weight loss, thymus atrophy, immunosuppression, and, at
high doses, death. The data in this paper show that at least one ofthese effects, weight
loss, is T cell mediated. Staphylococcal entertoxin-mediated weight loss is MHC
dependent, and is almost absent in animals expressing MHC class II molecules,
which, complexed with SEB, are poor T cell stimulants. Also, mice that lack T cell
function, genetically or because of cyclosporin A treatment, lose no or less weight
than controls in response to SEB. Finally, animals bred such that they express few
T cells bearing V,% with which SEB can interact lose much less weight in response
to the toxin than littermate controls that have higher numbers of reactive T cells.
It is therefore suggested that the pathological effects of the staphylococcal, T
cell-stimulating toxins in mouse and man may be partially or wholly the consequence
of massive T cell stimulation .
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